SANGRAIL
Live / Applied — New application — not yet assigned to an examiner (as of 22 Jan 2026)
What this means for you
Not registered yet, but its 22 Jan 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99608993
- Mark type
- Stylized text
- Filed
- 22 Jan 2026
- Attorney of record
- Jacqueline Lesser
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment of rare genetic diseases; pharmaceutical preparations primarily comprising cells for treatment of rare diseases; pharmaceutical preparations and therapeutic agents for use in gene therapy; pharmaceutical preparations for gene therapy for the treatment of genetic diseases or disorders; pharmaceutical preparations for use in the treatment of gene therapy treatable diseases.
- Class 042 — Scientific and technological services: Medical and scientific research in the field of gene therapy; medical and scientific research in the field of gene editing for developing cells and pharmaceuticals for medical and clinical use. Research and development of pharmaceuticals using gene editing
Owner
- Sangrail Biologics Inc., Philadelphia, PA, US
Prosecution history
- 22 Jan 2026 — APPLICATION FILING RECEIPT MAILED
- 22 Jan 2026 — NEW APPLICATION ENTERED